Compass Biotechnologies Inc. Shareholder Update
(firmenpresse) - LAKE MARY, FL -- (Marketwire) -- 12/14/12 -- Compass Biotechnologies Inc. (PINKSHEETS: COBI) or ("Compass") is pleased to update its shareholders and announce its intentions to move forward with its plans to refocus the core business model and direction of the company.
Under the direction of company's newly appointed CEO, Bradley Wilson, Compass has shifted its focus to the global Exploration and Energy sector, focusing on international properties that have established business assets, cash flow and sustainable operations to refocus our acquisition strategy.
Compass has hereby revoked the stock purchase agreement with 1WorldDirect US Inc., due to non performance. In light of the events, the Board is pleased to appoint Mr. Wilson, as he has established several relationships to acquire properties to expand the asset base of Compass. In addition, Compass will begin to divest itself of its biotech licenses, patents and assets over the next quarter to solely focus on energy and exploration.
Additional details will be forthcoming over the next several weeks and our new website will be available at: . The company will continue updating OTC Markets along with its website as a continued source of information to keep our shareholders up to date on all progress and developments.
Compass Biotechnologies Inc. is a diversified holding company that leverages emerging technologies in strategic alliances in the biotechnology market and is also transitioning its business model to the global exploration and resource sector.
Certain statements in this release, other than statements of historical fact, may include forward-looking information that involves various risks and uncertainties. There can be no assurance that such forward-looking statements will prove to be accurate. Actual result and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change, other than as required pursuant to applicable securities laws.
Compass Biotechnologies Inc.
1-800-537-4214
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.12.2012 - 17:21 Uhr
Sprache: Deutsch
News-ID 213012
Anzahl Zeichen: 0
contact information:
Town:
LAKE MARY, FL
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 252 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Compass Biotechnologies Inc. Shareholder Update"
steht unter der journalistisch-redaktionellen Verantwortung von
Compass Biotechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
